Search

everythinglearnresearchcommunity

for

Search:↓

Tofacitinib is effective and safe for severe hair loss, but full regrowth is less likely after 10 years of hair loss.

Lichen planus is a skin condition that can resolve on its own, is linked to hepatitis C, and increases the risk of skin cancer.

Patients with certain skin symptoms and high ANA titers should be monitored for potential systemic lupus.

JAK inhibitors help with skin conditions but need more research on dosing and safety.

New treatments for Alopecia Areata show promise but need to be more effective and affordable.

Alopecia Areata is an autoimmune condition often starting before age 20, with varied treatment success and a need for personalized treatment plans.

Cannabinoids may help treat chronic and chemotherapy-induced neuropathic pain, but more research is needed to confirm their effectiveness and safety.

Combining diphenylcyclopropenone with anthralin is more effective for hair regrowth in alopecia areata than using diphenylcyclopropenone alone, but may cause more side effects.

People with atopic dermatitis are more likely to develop other skin conditions due to shared genetics and immune pathways.

Using a gene therapy with the Sonic Hedgehog gene helps mice regrow hair faster after losing it from chemotherapy.

Acne is significantly influenced by genetics, and understanding its genetic basis could lead to better, targeted treatments.

People with lichen planus are more likely to have dyslipidemia, especially higher triglyceride levels.

Diphencyprone treatment increases CD8 lymphocytes in the scalp, which is associated with hair regrowth in alopecia areata patients.

Tannic acid helps wounds heal faster in rats by activating certain cell signals and reducing inflammation.

Many patients on new leukemia drugs had mild to moderate skin reactions.

Platelet-rich plasma (PRP) treatment has been found effective in promoting hair growth for alopecia patients, with minimal side effects like temporary pain and redness.

Alopecia areata causes hair loss due to an immune attack on hair follicles, influenced by genetics and environment.

Patients with severe alopecia areata have higher levels of MIF, which decrease after successful treatment.

308-nm excimer light therapy helped over a third of treatment-resistant alopecia universalis patients regrow most of their hair.

Immunomodulatory therapies are effective for treating cutaneous lymphoma, particularly in early stages.

Conditioned media from human amniotic fluid-derived stem cells helps skin heal and protects against aging from sun exposure.

The combination of gemcitabine and vinorelbine is effective and safe for treating elderly patients with advanced breast cancer previously treated with anthracyclines and taxanes.

Herbs might help with hair loss, but more research is needed to confirm their safety and effectiveness.

The conference highlighted new dermatological treatments and emphasized early intervention and addressing conditions lacking evidence-based treatments.

Two patients with the same genetic mutation had both blistering skin and easily pulled out hair.

Skin problems are common in Lupus patients and can indicate the disease's severity, requiring specific treatments and lifestyle changes.

Higher antigliadin antibodies are linked to more severe alopecia areata, suggesting screening for celiac disease in these patients.

COVID-19 can cause significant hair loss.

Comprehensive screening for infections is crucial before starting JAK inhibitors in alopecia areata patients.

Immune cells are essential for early hair and skin development and healing.